Evaxion Biotech Company

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

Employee Number: 51-100
Last Funding Type: Post-IPO Equity
Funding Status: IPO
Total Funding: 400000000
Last Funding Date: 2022-09-06
Industry: Immunotherapy Development
Estimated Revenue: $1M to $10M
Investors Number: 2.0
Founded Date: 2008-01-01
Technology: Biotechnology
Headquarters: Copenhagen, Hovedstaden, Denmark